Trade now with Barclays Stockbrokers
By Michele Maatouk
Date: Friday 31 Oct 2025
(Sharecast News) - AIM-listed Genedrive said on Friday that shareholder David Nugent had shown "willingness" to make a cash injection into the point-of-care pharmacogenetic testing company.
By Iain Gilbert
Date: Tuesday 28 Oct 2025
(Sharecast News) - Pharmacogenetic testing business Genedrive said on Tuesday that its exclusive distribution partner in the Kingdom of Saudi Arabia, iDeal iDea for Medical Equipment Technology, has signed a memorandum of understanding with the Saudi Arabian Ministry of Health.
By Josh White
Date: Monday 11 Aug 2025
(Sharecast News) - Genedrive said in an update on Monday that its full-year income for the 12 months ended June doubled to around £1m, from £0.5m a year earlier, driven by stronger second-half sales.
| Currency | UK Pounds | 
| Share Price | 1.04p | 
| Change Today | 0.19p | 
| % Change | 22.82 % | 
| 52 Week High | 2.50p | 
| 52 Week Low | 0.23p | 
| Volume | 99,194,108 | 
| Shares Issued | 1,029.60m | 
| Market Cap | £10.75m | 
| RiskGrade | 747 | 
| Value | 
		 | 
		
|---|
| Price Trend | 
		 | 
		
|---|
| Income | ![]()  | 
				
|---|
| Growth | 
		 | 
		
|---|
| No dividends found | 
| Time | Volume / Share Price | 
| 16:35 | 18,151 @ 1.04p | 
| 16:35 | 18,151 @ 1.04p | 
| 16:29 | 334,322 @ 1.00p | 
| 16:29 | 201,005 @ 1.00p | 
| 16:28 | 1,000,000 @ 0.97p | 
You are here: research